Scilex Company (SCLX) Revenue & Revenue Breakdown
Scilex Company Revenue Highlights
Latest Revenue (Y)
$46.74M
Latest Revenue (Q)
$16.37M
Scilex Company Revenue by Period
Scilex Company Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $46.74M | 22.90% |
2022-12-31 | $38.03M | 21.45% |
2021-12-31 | $31.32M | 32.92% |
2020-12-31 | $23.56M | 12.01% |
2019-12-31 | $21.03M | - |
Scilex Company Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | $16.37M | 50.40% |
2024-03-31 | $10.88M | -19.15% |
2023-12-31 | $13.46M | 33.06% |
2023-09-30 | $10.12M | -19.59% |
2023-06-30 | $12.58M | 18.90% |
2023-03-31 | $10.58M | -11.22% |
2022-12-31 | $11.92M | 4.76% |
2022-09-30 | $11.38M | 43.54% |
2022-06-30 | $7.93M | 16.35% |
2022-03-31 | $6.81M | -17.56% |
2021-12-31 | $8.26M | -0.71% |
2021-09-30 | $8.32M | 6.29% |
2021-06-30 | $7.83M | - |
2021-03-31 | $7.83M | 32.92% |
2020-12-31 | $5.89M | - |
2020-09-30 | $5.89M | - |
2020-06-30 | $5.89M | - |
2020-03-31 | $5.89M | 12.01% |
2019-12-31 | $5.26M | - |
2019-09-30 | $5.26M | - |
2019-06-30 | $5.26M | - |
2019-03-31 | $5.26M | - |
Scilex Company Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
MRK | Merck | $60.12B | $16.66B |
ABBV | AbbVie | $54.32B | $14.46B |
NVS | Novartis | $46.66B | $11.83B |
AZN | AstraZeneca | $45.81B | $12.68B |
BMY | Bristol-Myers Squibb Company | $45.01B | $11.89B |
SNY | Sanofi | $43.07B | $11.12B |
LLY | Eli Lilly and Company | $34.12B | $11.44B |
GSK | GSK | $30.33B | $7.36B |
AMGN | Amgen | $28.19B | $8.50B |
GILD | Gilead Sciences | $27.12B | $7.55B |
BIIB | Biogen | $9.84B | $2.47B |
SCLX | Scilex Company | $46.74M | $16.37M |